跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUMIGAN 0,3 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LUMIGAN 0,3 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Approved
STANDARD
LUMIGAN 0,3 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Allergan Pharmaceuticals Ireland
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 9, 2022
Approval ID
fe7930335cfdcd6c
Company
Allergan Pharmaceuticals Ireland
Type
Standard
Approval Details
Approval Id
fe7930335cfdcd6c
Drug Cima Aemps Name
LUMIGAN 0,3 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Register Number
02205006IP
Holder Company Name
Allergan Pharmaceuticals Ireland
Marketing Company Name
Difarmed S.L.
Holder Company Detail Path
/organization/allergan-pharmaceuticals-ireland
Authorization Date
2022-05-09
Dosage Form
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Dose
0,3 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Allergan Pharmaceuticals Ireland
Company Detail Path
/organization/allergan-pharmaceuticals-ireland
Company Information
Pharmaceutical Company Name
Allergan Pharmaceuticals Ireland
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Active Ingredients
BIMATOPROST
0,3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 9, 2022
Approval ID
fe7930335cfdcd6c
Type
Standard
Back to CIMA-AEMPS Approvals